|
| Wednesday, July 5, 2023 |
|
|
Dogtainers and Dr. Harry: Discover the Fascinating World of Animal Transit |
| Animals Aboard with Dr. Harry, a brand new series, is set to launch on July 5, 2023. The show explores the fascinating stories of animals in transit around the globe, supported by one of the world's largest pet transportation companies, Dogtainers. more info >> |
|
|
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345 |
| Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older. more info >> |
|
| Friday, June 30, 2023 |
|
|
Cure Brain Cancer Foundation Unveils Fellowship Awardees |
| Cure Brain Cancer Foundation (CBCF) is pleased to announce the highly anticipated recipients of this year's prestigious Early Career Fellowships. This unrivaled funding opportunity is set to empower researchers, propelling them closer to breakthrough discoveries in the battle against brain cancer. more info >> |
|
| Thursday, June 29, 2023 |
|
|
Solar Powered Sunscreen: EcoZinc a World First in Sustainable Zinc Oxide Innovation |
| Advance ZincTek, Australia's leading manufacturer of natural Sunscreen Actives, announces the launch of EcoZinc, the world's first solar-powered, non-nano zinc oxide powder for SPF-rated cosmetics and sunscreens. EcoZinc not only minimizes environmental impact, but also achieves a dramatic reduction in carbon emissions-saving over 1011g of CO2 per kilowatt of energy used compared to traditional zinc oxide production. more info >> |
|
|
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun |
| NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies. more info >> |
|
|
ビットコインに支えられた新しいEVMレイヤー2、「Rollux」が稼働開始 |
| Syscoinが運営するWeb3製品スイートであるSYS Labsは、革新的なEVMレイヤー2ソリューションであるRolluxのローンチを発表しました。Rolluxはビットコインの強みを活用することにより、イーサリアムネットワークアプリケーションのパフォーマンスを最適化するように設計されているため、SYS Labsを競合他社から差別化する独自のイーサリアムのスケーリングアプローチを提示しています。 more info >> |
|
|
基于比特币的新颖EVM层2方案Rollux上线 |
| 由Syscoin驱动的Web3产品套件SYS Labs宣布推出创新的EVM Layer-2解决方案Rollux。Rollux旨在优化以太坊网络应用的性能，利用比特币的强大力量，为以太坊的扩展提出了独特的方法，这使SYS Labs与竞争对手有所区别。 more info >> |
|
|
太平洋綠色公司以7,400萬英鎊（9300萬美元）的價格完成了其99兆瓦Richborough能源園電池項目的出售交易 |
| 太平洋綠色科技公司（Pacific Green Technologies, Inc.，OTCQB:PGTK）宣布已將其子公司Pacific Green Battery Energy Parks 1 Limited（PGBEP1）的100%股權出售給Sosteneo Fund 1 HoldCo S.à.r.l，交易價格為7,400萬英鎊（9300萬美元），該公司是一家專注於能源轉型的基金。 more info >> |
|
|
太平洋绿色公司以7,400万英镑（9300万美元）的价格完成了其99兆瓦Richborough能源园电池项目的出售交易 |
| 太平洋绿色科技公司（Pacific Green Technologies, Inc.，OTCQB:PGTK）宣布已将其子公司Pacific Green Battery Energy Parks 1 Limited（PGBEP1）的100%股权出售给Sosteneo Fund 1 HoldCo S.à.r.l，交易价格为7,400万英镑（9300万美元），该公司是一家专注于能源转型的基金。 more info >> |
|
|
A Breakthrough in Metal Packaging: Eviosys Launches 'Ecopeel', a Revolutionary New Dual Product of Can and Peelable End |
| International packaging giant Eviosys has revealed its latest innovation, Ecopeel. 200 years of expertise and innovation has produced an industry first: a processable food can with a sleek, peelable foil directly sealed on the can body. more info >> |
|
|
|
|
